Finally, rapamycin exhibits potent anti-oral cancer properties through inhibition of several cancer-promoting pathways (MAPK, NF-κB, and Wnt/beta-catenin). The gene discussed is CTNNB1; the disease is lip and oral cavity carcinoma.